Aerogen news
Aerogen Pharma, a developer of innovative inhaled treatments for patients in critical care, and Nuance Pharma (“Nuance”), a specialty care focused biopharma with late-stage clinical programs and existing commercial operations, today announce an exclusive agreement to join forces in Greater China to develop a superior, non-invasive approach to treatment of RDS, a life-threatening condition of preterm infants associated with long-term lung health issues in survivors.
The lic
Following months of collaborative development work, Aerogen® (Galway, Ireland) and CanSinoBIO (SSE: 688185, HKEX: 06185) (Tianjin, China) have announced a development and commercial supply partnership for the inhaled delivery of CanSinoBIO’s Recombinant Novel Coronavirus Vaccine Convidecia™ utilizing Aerogen’s proprietary vibrating mesh aerosol drug delivery technology.
The aerosolised vaccine is directly inhaled via a cup dispenser into the patient’s airwa
Company’s aerosol drug delivery technology used in Phase 1 clinical trial to deliver inhaled type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults without COVID-19 from China
The Aerogen Solo is a closed-system, single-patient-use aerosol drug delivery technology1 that mitigates the transmission of patient-generated infectious aerosol during ventilation
The National Patient Safety Agency recently issued an alert (NatPSA/2021/003/NHSPS) necessitating organisations to “purchase sufficient powered nebuliser devices for use across the organisation; to remove the need for medical air to drive nebulisers via a flowmeter”. It states that all NHS hospitals are required to be fully compliant by the 16th N
UNICEF Ireland welcomes two-year partnership with Galway-based Aerogen
UNICEF and Aerogen have announced a two-year partnership in support of UNICEF’s work in the areas of global vaccine equity and the health of newborns.
In 2021, Aerogen has committed €50,000 to go towards funding UNICEF’s delivery of 2 billion COVID-19 vaccines to the most vulnerable families, health workers and high-risk people on our planet. As the